Fig. 39From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseCoumarin alkylamines C41m–C41s (entry 13–19)Back to article page